BIOVIE INC. — Director's Dealing 2021

Sep 29, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOVIE INC. (BIVI)
CIK: 0001580149
Period of Report: 2021-08-20

Reporting Person: Ahlem Clarence N. (EVP Neuroscience Product Dev.)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-20	Stock Option (right to buy)	$7.74	A	124167	Acquired	2031-08-19	COMMON STOCK (124167)	Direct

Footnotes

F1: This option was 20% vested upon grant, with an additional 16% on each of the first five anniversaries of the grant.